Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9MA8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,129
Award facts
- Contract value 100% obligated
- $22,128.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,128.50 to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This non-competitive delivery order carries a firm fixed price structure and is scheduled for completion by January 21, 2026, with performance at the vendor's Conshohocken, Pennsylvania facility. The award represents a task order against AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting Department of Defense and military healthcare systems. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Biktarvy, an antiretroviral medication, reflects the company's ongoing role in supplying essential pharmaceutical products to military treatment facilities and federal healthcare institutions through competitively-awarded contract vehicles.
Quick answers
Who was awarded contract SPE2DR26F9MA8?
SPE2DR26F9MA8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9MA8 worth?
The government has obligated $22,129 on SPE2DR26F9MA8.
Is contract SPE2DR26F9MA8 an order under another contract?
Yes. SPE2DR26F9MA8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MA8 competed?
The extent of competition for SPE2DR26F9MA8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award